Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06349564 · ClinicalTrials.gov registry record · NA
Implementing Virtual Reality (VR) to Reduce Sedation
A NA study of Sedative During Endoscopy, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06349564: Recruiting NA study of Sedative During Endoscopy, sponsored by NYU Langone Health.
NCT06349564 is a NA study of Sedative During Endoscopy that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06349564, a NA study of Sedative During Endoscopy, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is a prospective pilot patients aged 21 to 65 undergoing screening colonoscopy or diagnostic upper endoscopy. Patients are administered minimal sedation (2 mg of Versed and 25 mg of Fentanyl) and are given Virtual Reality (VR) goggles to wear for the duration of the procedure. The purpose of this study is to assess the feasibility, effect, and safety of using VR goggles during endoscopic procedures to decrease sedation requirements, enhance patient satisfaction, and reduce recovery time.
Conditions Studied
Interventions
- DEVICE Pico 4 Enterprise headset with noise cancelling headphones
Study Locations (1)
New York
- NYU Langone Brooklyn - Brooklyn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-12-09 |
| Est. Completion | 2026-09 |
| Phase | NA |
What NCT06349564 shows while recruiting
NCT06349564 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Sedative During Endoscopy appearing as the primary indexed condition, and to 1 intervention - of which Pico 4 Enterprise headset with noise cancelling headphones is the first listed.
NCT06349564 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06349564 about?
NCT06349564 is a clinical study titled "Implementing Virtual Reality (VR) to Reduce Sedation". The study is a prospective pilot patients aged 21 to 65 undergoing screening colonoscopy or diagnostic upper endoscopy. Patients are administered minimal sedation (2 mg of Versed and 25 mg of Fentanyl) and are given Virtual Reality (VR) goggles to wear for the duration of the procedure. The purpose ...
What is the current status of trial NCT06349564?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2024-12-09. Estimated completion is 2026-09.
What conditions does trial NCT06349564 study?
This clinical trial studies the following conditions: Sedative During Endoscopy.
What interventions are being tested in trial NCT06349564?
The interventions under investigation include: Pico 4 Enterprise headset with noise cancelling headphones (DEVICE).
Who is sponsoring clinical trial NCT06349564?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06349564 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06349564's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI